![Yoshitsuga Shitaka](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Yoshitsuga Shitaka
Presidente en OCATA THERAPEUTICS INC .
Cargos activos de Yoshitsuga Shitaka
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
OCATA THERAPEUTICS INC | Director/Miembro de la Junta | - | - |
Director Técnico/Científico/I+D | - | - | |
Presidente | - | - | |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Director Ejecutivo | - | - |
Historial de carrera de Yoshitsuga Shitaka
Estadísticas
Internacional
Estados Unidos | 3 |
Operativa
Director/Board Member | 1 |
Chief Tech/Sci/R&D Officer | 1 |
President | 1 |
Sectorial
Health Technology | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas privadas | 2 |
---|---|
Astellas Institute for Regenerative Medicine
![]() Astellas Institute for Regenerative Medicine Pharmaceuticals: MajorHealth Technology Astellas Institute for Regenerative Medicine engages in the development and commercialization of human pluripotent stem cell technology in the field of regenerative medicine. The company also have a preclinical development pipeline in areas outside of ophthalmology, including; autoimmune diseases, inflammatory diseases, and wound healing. The company was founded on May 18, 2000 and is headquartered in Marlborough, MA. | Health Technology |
Agensys, Inc.
![]() Agensys, Inc. Miscellaneous Commercial ServicesCommercial Services Agensys, Inc. develops a pipeline of therapeutic fully human monoclonal atibodies (mAbs) to treat cancer. It develops a pipeline of naked and antibody-drug conjugated (ADC) therapeutic antibodies to treat cancer indications, including prostate, kidney, pancreas, ovary, bladder, lung, colon, breast, and skin. The company was founded in 1997 and is headquartered in Santa Monica, CA. | Commercial Services |
- Bolsa de valores
- Insiders
- Yoshitsuga Shitaka
- Experiencia